Charles Pauling Semba, Director of DiaMedica Therapeutics DMAC, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/01.

CS

CS

Charles Pauling Semba

Director

Company

DiaMedica Therapeutics DMAC

First filing

23/01/03

Trades

9 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
DiaMedica TherapeuticsDMAC	Open-market buy	23/06/23	23/06/26	12,787 sh	$3.91	$49,997.17	+74.5%